This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Movement Disorders  • Parkinson Disease/ Parkinsonian Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Neurol. 2006;63:807-808.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Parkinson disease (PD) is a progressive neurodegenerative movement disorder characterized by resting tremor, bradykinesia, rigidity, and postural instability. Definitive diagnosis of PD is based on several pathological postmortem criteria, including the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy body pathology. Although the etiology of PD is unknown, the recent discovery that a small but significant genetic component exists has provided novel insight into the molecular pathways involved in disease pathogenesis. The major genetic loci associated with PD are PARK1 (-synuclein) and PARK8 (LRRK2/dardarin) which cause an autosomal dominant form of PD while mutations in PARK2 (parkin), PARK6 (PINK1), and PARK7 (DJ-1) lead to an autosomal recessive form of the disease, primarily among patients with the early-onset form, with age of onset before 50 years. It is still unclear whether the mutations, associated with early-onset PD also contribute to idiopathic PD.¹

The . . . [Full Text of this Article]

AUTHOR INFORMATION

Uwe Beffert, PhD; Roger N. Rosenberg, MD, Editor

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Influence of Heterozygosity for Parkin Mutation on Onset Age in Familial Parkinson Disease: The GenePD Study
Mei Sun, Jeanne C. Latourelle, G. Frederick Wooten, Mark F. Lew, Christine Klein, Holly A. Shill, Lawrence I. Golbe, Margery H. Mark, Brad A. Racette, Joel S. Perlmutter, Abbas Parsian, Mark Guttman, Garth Nicholson, Gang Xu, Jemma B. Wilk, Marie H. Saint-Hilaire, Anita L. DeStefano, Ranjana Prakash, Sally Williamson, Oksana Suchowersky, Nancy Labelle, John H. Growdon, Carlos Singer, Ray L. Watts, Stefano Goldwurm, Gianni Pezzoli, Kenneth B. Baker, Peter P. Pramstaller, David J. Burn, Patrick F. Chinnery, Scott Sherman, Peter Vieregge, Irene Litvan, Tammy Gillis, Marcy E. MacDonald, Richard H. Myers, and James F. Gusella
Arch Neurol. 2006;63(6):826-832.
ABSTRACT | FULL TEXT  

Clinical Spectrum of Homozygous and Heterozygous PINK1 Mutations in a Large German Family With Parkinson Disease: Role of a Single Hit?
Katja Hedrich, Johann Hagenah, Ana Djarmati, Anja Hiller, Thora Lohnau, Kathrin Lasek, Anne Grünewald, Rüdiger Hilker, Susanne Steinlechner, Heather Boston, Norman Kock, Christiane Schneider-Gold, Wolfram Kress, Hartwig Siebner, Ferdinand Binkofski, Rebekka Lencer, Alexander Münchau, and Christine Klein
Arch Neurol. 2006;63(6):833-838.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant {alpha}-Synuclein
Lu et al.
J. Neurosci. 2009;29:1962-1976.
ABSTRACT | FULL TEXT